Диссертация (1140237), страница 17
Текст из файла (страница 17)
55. – P. 403–408.64. Garcia-Pagan J.C, Caca K., Bureau C., Laleman W., Appenrodt B., Luca A., etal. Early use of TIPS in patients with cirrhosis and variceal bleeding // New EnglandJournal of Medicine. – 2010. – № 362. – P. 2370–2379.65. Garcia-Tsao G., Bosch J. Management of varices and variceal hemorrhage incirrhosis // N. Engl. J. Med. – 2010. – Vol. 362. – P. 823–832. Hepatology: a clinicaltextbook. 5th ed. Ed. by Mauss, Berg, Rockstroh, Sarrazin, Wedemeyer.
– Flying publisher, 2014.66. Garcia-Tsao G., Bosch J., Groszmann R. J. Portal Hypertension and VaricealBleeding — Unresolved Issues. Summary of an American Association for the Study ofLiver Diseases and European Association for the Study of the Liver Single-Topic Conference // Hepatology. – 2008 – Vol. 47. – № 5.67. Garcia-Tsao G., Friedman S., Iredale J., Pinzani M. Now There Are Many(Stages) Where Before There Was One: In Search of a Pathophysiological Classification of Cirrhosis // Hepatology.
– 2010. – Vol. 51. – № 4. – P. 1445–1449.68. Gines P., Fernandez J., Durand F., Saliba F. Management of critically-ill cirrhotic patients // Nature. – 2009. – Vol. 6. – P. 573–582.69. Gracia-Sancho J., Maeso-Díaz R., Bosch J. Pathophysiology and a RationalBasis of Therapy // Journal of Digestive Disease.
– 2015. – Vol. 33. – № 4. – P. 508–514.70. Grigorescu M. Noninvasive Biochemical Markers of Liver Fibrosis // JournalGastrointestinal and Liver Disease. – 2006. – Vol. 15. – № 2. – P. 149–159.71. Groszmann R. J., Wongcharatrawee S. The hepatic venous pressure gradient:anything worth doing should be done right // Hepatology. – 2004.
– № 39. – P. 280–282.72. Guo Y. L., Lu X. L., Cheng Y., Shi H. T., Xie D. H., Li H., Dong L. Combination measurement of liver and spleen stiffness with portal vein width to evaluate risk of108bleeding in esophageal and gastric varices patients // Zhonghua Gan Zang Bing ZaZhi. – 2016. – Vol. 24. – № 1. – P. 56–61.73. Hytiroglou P., Snover D.
C., Alves M., Balabaud C., Bhathal P. S., BioulacSage P., et al. Beyond ―Cirrhosis‖ A Proposal From the International Liver PathologyStudy Group // American Journal of Clinical Pathology – 2012. – № 137. – P. 5–9.74. Iwakiri Y. Pathophysiology of portal hypertension // Clin. Liver Dis. – 2014. –Vol. 18. – № 2. – P. 281–291.75. Kim M.
Y., Woo K. J., Soon K. B. Invasive and non-invasive diagnosis of cirrhosis and portal Hypertension // World Journal of Gastroenterology. – 2014. –Vol. 20. – № 15. – P. 4300–4315.76. La Brecque D., Khan A. G., Sarin S. K., Le Mair A. W. World Gastroenterology Organisation Global Guidelines. Practice Guideline Esophageal Varices // WorldGastroenterologyOrganisation[Электронныйресурс]. –Режимhttp://www.worldgastroenterology.org/guidelines/global-guidelines/доступа:esophageal-varices/esophageal-varices-english/77. La Mura V., Nicolini A., Tosetti G., Primignani M. Cirrhosis and portal hypertension: The importance of risk stratification, the role of hepatic venous pressure gradient Measurement // World Journal of Hepatology.
– 2015. – Vol. 7. – № 4. – P. 688–695.78. Lemoine M., Katsahian S., Ziol M., Nahon P., Ganne-Carrie N., Kazemi F., etal. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis // Alimentary Pharmacology and Therapy. – 2008. – № 28. – P. 1102–1110.79. Lok A.
S. et al. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort // Hepatology. – 2005. – Vol. 42. –P. 282–292.80. Lombardi R., Buzzetti E., Roccarina D., Tsochatzis E. Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease // World Journal of Gastroenterology.
– 2015. – Vol. 21. – № 39. – P. 11044–11052.10981. Marra F., Arena U., Vizzutti F., Abraldes J. G., Corti G., Stasi C. Reliability oftransient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C //Gut. – 2008. – Vol. 57. – № 9. – P. 1288–1293.82. Masuzak R., Yamashiki N., Sugawara Y., Yoshida H., Tateishi R., Tamura S.Assessment of liver stiffness in patients after living donor liver transplantation by transient elastography // Scandinavian Journal of Gastroenterology. – 2009. – № 44. –P.
1115–1120.83. Mokdad A. A.,Lopez A. D.,Shahraz S.,Lozano R.,Mokdad A. H.,Stanaway J., et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: asystematic analysis // BMC Medicine. – 2014. – № 12. – P. 145.84. Moreau R., Jalan R., Gines P., Pavesi M., Angeli P., Cordoba J., Durand F., etal. Acute-on-Chronic liver failure is a distinct syndrome that develops in patients withacute decompensation of cirrhosis // Gastroenterology. – 2013. – № 144. – P. 1426–1437.85.
Mueller S., Karl Seitz H. K., Rausch V. Non-invasive diagnosis of alcoholicliver disease // World Journal of Gastroenterology. – 2014. – Vol. 20. – № 40. –P. 14626–14641.86. Norström T., Ramstedt M. Mortality and population drinking: a review of theliterature // Drug. Alcohol. Rev. – 2005. – Vol. 4. – № 6. – P. 537–547.87. Novelli P. M., Cho K., Rubin J. M.
Sonographic assessment of spleen stiffnessbefore and af-ter transjugular intrahepatic portosystemic shunt placement with or without concurrent em-bolization of portal systemic collateral veins in patients with cirrhosis and portal hypertension: a feasibility study // J. Ultrasound. Med. – 2015. –Vol. 34.
– № 3. – P. 443–449.88. Ophir J. et al. Elastography: Imaging the Elastic Properties of Soft Tissues withUltrasound // J. Med. Ultrasonics. – 2002. – P. 155–171.89. Pavlov C. S., Casazza G., Nikolova D., Tsochatzis E., Burroughs A. K., Ivashkin V. T., Gluud C. Transient elastography for diagnosis of stages of hepatic fibrosisand cirrhosis in people with alcoholic liver disease // Cochrane Database of SystematicReviews. – 2015. – Is. 1. – № CD010542.11090.
Pavlov C. S., Casazza G., Semenistaia M., Nikolova D., Tsochatzis E., Liusina E., Ivashkin V. T., Gluud C. Ultrasonography for diagnosis of alcoholic cirrhosisin people with alcoholic liver disease (Review) // Cochrane Database of Systematic Reviews. – 2016. – Is. 3. – № CD011602.91. Parkes J., Roderick P., Harris S., Day C., Mutimer D., Collier J., Lombard M.,Alexander G. et al. Enhanced liver fibrosis test can predict clinical outcomes in patientswith chronic liver disease // Gut. – 2010.
– Vol. 59. – № 9. – P. 1245–51.92. Perelló A., Escorsell A., Bru C., et al. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis // Hepatology. –1999. – Vol. 30. – № 6. – P. 1393–1397.93. Pinzani M., Pathophysiology of Liver Fibrosis // Digestive Disease. – 2015. –№ 33. – P.
492–497.94. Pinzani M., Rombouts K., Colagrande S. Fibrosis in chronic liver diseases: diagnosis and management // Journal of Hepatology. – 2005. – № 42. – P. 22–36.95. Qamar A. A., Grace N. D., Groszmann R. J., et al. Incidence, prevalence andclinical significance of abnormal hematologic indices in compensated cirrhosis // Clinical gastroenterology and hepatology. – 2009. – Vol. 7. – № 6.
– P. 689–695.96. Ripoll C., Bañares R., Rincón D., Catalina M. V., Lo Iacono O., Salcedo M., etal. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era // Hepatology. – 2005. Vol. 42. – P. 793–801.97. Rosselli M., Macnaughtan R., Jalan R., Pinzani M. Beyond scoring: a moderninterpretation of disease progression in chronic liver disease // Gut. – 2013. – Vol. 62. –№ 9.
– P. 1234–1241.98. Schuppan D., Afdhal N. H. Liver cirrhosis // Lancet. – 2008. – № 371. –P. 838–851.99. Sharma P., Kirnake V., Tyagi P., Bansal N., Singla V., Kumar A., Arora A.Spleen stiffness in patients with cirrhosis in predicting esophageal varices // AmericanJournal of Gastroenteroligy.
– 2013. – Vol. 108. – № 7. – P. 1101–1107.111100. Stefanescu H., Procopet B., Noninvasive assessment of portal hypertension incirrhosis: Liver stiffness and beyond // World Journal of Gastroenterology. – 2014. –Vol. 20. – № 45. – P. 16811–16819.101.
Suk T. K., Hepatic venous pressure gradient: clinical use in chronic liver disease // Clin. Mol. Hepatol. – 2014. – Vol. 20. – № 1. – P. 6–14.102. Testa R., Testa E., Giannini E., Borro P., Milazzo S., Isola L., Ceppa P.,Lantieri P. B., Risso D.
Noninvasive ratio indexes to evaluate fibrosis staging in chronichepatitis C: role of platelet count/spleen diameter ratio index // Journal of Internal Medicine. – 2006. – Vol. 260. – № 2. – P. 142–50.103. Triantos C. K., Nikolopoulou V., Burroughs A. K. Review article: the therapeutic and prognostic benefit of portal Pressure reduction in cirrhosis // AlimentaryPharmacology and Therapy. – 2008. – № 28. – P. 943–952.104. Tsochatzis E., Bruno S., Isgro G., Hall A., Theocharidou E., Manousou P.,Dhillon A. P., Burroughs A. K., Luong T.
V. Collagen proportionate area is superior toother histological methods for sub-classifying cirrhosis and determining prognosis //Journal of Hepatology. – 2014. – Vol. 60. – P. 948–954.105. Tsochatzis E., Calvaruso V., Dhillon A. P., Manousou P., Grillo F., Germani G., et al. Liver collagen proportionate area predicts decompensation in patients withrecurrent hepatitis C virus cirrhosis after liver transplantation // Journal of Gastroenterology and Hepatology. – 2012. – Vol. 27.
– P. 1227–1232.106. Vizzutti F., Arena U., Romanelli R. G., Rega L., Foschi M., Colagrande S., etal. Liver stiffness measurement predicts severe portal hypertension in patients withHCV-related cirrhosis // Hepatology. – 2007. – Vol. 45. – № 5.107. Westbrook C., Rachel H., Dusheiko G. Natural history of hepatitis // Journalof Hepatology. – 2014. – Vol.
61. – P. 58–68.108. WHO. European Status Report on Alcohol // World Health Organisation.[Электронныйресурс]. –Режимhttp://www.euro.who.int/__data/assets/pdf_file/0004/128065/e94533.pdf112доступа:109. Zehetner J., Shamiyeh A., Wayand W., Hubmann R. Results of a new methodto stop acute bleeding from esophageal varices: implantation of a self-expanding stent //Surg Endosc. – 2008. – Vol. 22. – P. 2149–2152.110. Zykus R., Jonaitis L., Petrenkienė V., Pranculis A., Kupčinskas L.
Liver andspleen transient elastography predicts portal hypertension in patients with chronic liverdisease: a prospective cohort study // BMC Gastroenterol. – 2015. – Vol. 15. – № 1. –P. 183.113.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
